Search for: "Lilly France"
Results 101 - 120
of 135
Sort by Relevance
|
Sort by Date
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
13 Jul 2011, 3:04 am
(IP Watch) BRIC health ministers’ meeting – Beijing declaration (KEI) “Lilly’s pipeline remains incapable of replacing patent-related losses” (IPBiz) A new book – and a competition! [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
31 May 2011, 8:38 pm
Novo Nordisk (Orange Book Blog) Silenor (Doxepin) – US: Somaxon files patent infringement lawsuit against Par Pharmaceuticals over bid to market generic Silenor (GenericsWeb) Strattera (Atomoxetine) – US: Eli Lilly files patent infringement complaint against Zydus in response to Para IV certification (Patent Docs) Zemplar (Paricalcitol) – US: Abbott Lab’s files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs) Ziana… [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
6 Apr 2011, 12:18 am
GSK Biologicals (EPLAW) France: Cour de cassation decision in case for infringement of European patent relating to ‘cloned DNA sequences, hybridizable with genomic RNA of the LAV’: Institut Pasteur v. [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium… [read post]
24 Jan 2011, 4:55 am
Finally Matt addressed industrial applicability, there being a new case to cite in Eli Lilly v Human Genome Sciences Inc, as well as a string of perpetual motion machines. [read post]
7 Dec 2010, 11:13 pm
Partners of the national law firms Cabinet Gelly (France), Van Bael & Bellis (Belgium), Bristows (UK), Panetta & Associati (Italy), Houthoff Buruma (Netherlands), Coelho Ribeiro E Associados (Portugal and Spain), Baker & Daniels (USA), and Hunton & Williams (USA). [read post]
10 Nov 2010, 1:11 am
General Global Fund calls upon drug companies to ‘share without delay’ AIDS drug patents with the Medicines Patent Pool (KEI) Sharing US drug patents with neglected patients: A scientist’s view (IP Watch) Statement of the United States to WTO TRIPS Council on the Paragraph 6 System (KEI) Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilities (KEI) Seed patents and biodiversity (Patent Baristas) BIO’s… [read post]
7 Jul 2010, 5:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) - EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat) General An overview of the… [read post]
6 Jul 2010, 6:03 pm
Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) – EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat) General An overview of the ‘Health Impact Fund’ model for accessible medicines (Spicy IP) Pharma pay-and-procure symposium (IP finance) Australia:… [read post]
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of Metropolitan… [read post]
2 Apr 2010, 7:00 am
O hacker concedeu uma entrevista ao site francês Zatazm, onde contou todo o trabalho que teve para conseguir invadir o Twitter. [read post]
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Zyrtec (Cetirizine) - France: Tribunale de Grande Instance finds lack of inventive step: Teva Classics SAS, Teva Sante SASU and Teva Pharmaceutical Industries Ltd v. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow… [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
2 May 2009, 10:12 am
LILLI M. [read post]
